Olema Pharmaceuticals inc logo

Olema Pharmaceuticals inc

1
NAS:OLMA (USA)   Ordinary Shares
$ 9.84 +0.18 (+1.86%) 10:08 PM EST
At Loss
P/B:
2.28
Market Cap:
$ 550.39M
Enterprise V:
$ 293.55M
Volume:
547.80K
Avg Vol (2M):
780.59K
Volume:
547.80K
At Loss
Avg Vol (2M):
780.59K

Business Description

Olema Pharmaceuticals inc logo
Olema Pharmaceuticals inc
NAICS : 325412 SIC : 2834
ISIN : US68062P1066

Share Class Description:

OLMA: Ordinary Shares
Description
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Name Current Vs Industry Vs History
Cash-To-Debt 112.71
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.24
9-Day RSI 42.37
14-Day RSI 42.6
6-1 Month Momentum % -32.68
12-1 Month Momentum % 54.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.61
Quick Ratio 9.61
Cash Ratio 9.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.8
Shareholder Yield % -1.39

Financials (Next Earnings Date:2024-08-08 Est.)

OLMA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OLMA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Olema Pharmaceuticals inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.01
Beta 2.38
Volatility % 80.45
14-Day RSI 42.6
14-Day ATR ($) 0.832535
20-Day SMA ($) 10.1125
12-1 Month Momentum % 54.1
52-Week Range ($) 5.02 - 17.7911
Shares Outstanding (Mil) 55.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Olema Pharmaceuticals inc Filings

Filing Date Document Date Form
No Filing Data

Olema Pharmaceuticals inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Olema Pharmaceuticals inc Frequently Asked Questions

What is Olema Pharmaceuticals inc(OLMA)'s stock price today?
The current price of OLMA is $9.84. The 52 week high of OLMA is $17.79 and 52 week low is $5.02.
When is next earnings date of Olema Pharmaceuticals inc(OLMA)?
The next earnings date of Olema Pharmaceuticals inc(OLMA) is 2024-08-08 Est..
Does Olema Pharmaceuticals inc(OLMA) pay dividends? If so, how much?
Olema Pharmaceuticals inc(OLMA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1